LGP.AX Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: July 28, 2025
Report Source: 2025 Annual Report
Little Green Pharma Ltd. Stock Analysis LGP.AX
Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. Its principal activities include the cultivation of medicinal cannabis, procurement of raw materials and production of medicinal cannabis medicines; the supply of medicinal cannabis products into Australia and Europe; the supply of medicinal cannabis products for observational and clinical studies and research and development of new medicinal cannabis products, and the development of a psychedelics business including sponsoring a clinical trial into the treatment of refractory depression with psilocybin assisted therapy, construction of a psilocybin mushroom cultivation facility, and establishment of a psychedelic treatment clinic. The company has a diverse and growing portfolio of cannabis-based medicines, distributed across Australia and over 12 export markets.
Read More Little Green Pharma Ltd (LGP.AX) Chart
Key Statistics of Little Green Pharma Ltd (LGP.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.10Volume
501.97KP/E Ratio (TTM)
9.1152 Week Range
Market Cap
29.97MAvg. Volume
100.12KDividend Yield
-Financial Metrics & Statements of Little Green Pharma Ltd (LGP.AX)
FAQ's for Little Green Pharma Ltd (LGP.AX)
- According to Musaffa’s Shariah screening methodology, Little Green Pharma Ltd (LGP.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.